Dr. Noon for Health Care Professionals
Identify hidden CVD risk earlier
Instant at the point of care
Non-invasive and instant screening, before symptoms or events
Supports earlier intervention and more targeted referrals
Clinically validated AI with high diagnostic accuracy
Deliver rapid, specialist-level
cardiovascular risk insight
at the point of care
From imaging that can be performed in primary care, hospital services, or community optometry referral pathways.
CVD facts
No.1
Cause of death in the UK
7.6M
People living with heart or circulatory disease
£9B
Annual cost to the NHS.
85%
of total deaths are preventable
*British Heart Foundation, Cardiovascular Disease Statistics 2024
Smarter tools for everyday clinical care
Dr.Noon brings AI-powered screening into primary and specialty care, helping providers catch silent risks sooner and act with confidence.
Primary Care & Routine Consultations
- Opportunistic CVD risk detection
- Supports earlier triage and prevention planning
- Identifies high-risk patients who may otherwise go unnoticed
Chronic Disease Pathways
- Adds vascular risk context to chronic disease management
- Supports earlier treatment optimization
- Helps stratify patients needing escalation
Screening & Population Health Programmes
- Enables scalable cardiovascular screening
- Improves detection yield in large cohorts
- Supports targeted specialist referral and resource allocation
Deliver rapid, specialist-level CVD risk insight at the point of care
Designed for seamless integration into existing care pathways with minimal infrastructure requirements
Enable a shift from reactive to preventive care
- AI analyses subtle retinal vascular changes to predict cardiovascular risk
- Detect cardiovascular risk before symptoms or acute events occur, including in asymptomatic patients
- Broadens screening opportunities by integrating risk assessment into routine imaging and checkups
Support earlier, potentially life-saving interventions
- Provides early risk insight to support timely lifestyle or pharmacological treatment decisions
- Helps identify patients who may benefit from earlier specialist referral
- Supports intervention planning during earlier, more manageable disease stages
Save specialist time
- Supports risk-based referral prioritization
- Helps reduce avoidable or low-value specialist consultations
- Enables more focused use of specialist expertise and clinical capacity
Improve long-term outcomes
- Supports earlier management of cardiovascular risk factors
- May help reduce disease progression and associated complications
- Contributes to improved patient quality of life and disease control
Reduce long-term healthcare costs
- Supports prevention strategies that may reduce emergency and late-stage treatment costs
- Enables scalable screening using existing imaging infrastructure
- Supports more efficient allocation of healthcare resources
Cardiovascular Risk and retinal disease detection
Instant risk assessment in seconds
AI analyses retinal vessel patterns and provides a clear risk assessment: Low, Moderate, or High Risk.
Detects retinal diseases with 96% accuracy
AI-powered precision that matches real ophthalmologists.
Strong predictive performance
Clearer risk stratification than traditional hospital-based methods.
Screens for key retinal conditions
Diabetic Retinopathy, Macular Degeneration, Glaucoma, Cataract
Seamless integration
Dr. Noon fits effortlessly into existing care workflows and screening programs, making adoption simple across clinical settings, at any scale.
Instant, In-Situ Screening
AI-powered screening from a single retinal scan. Non-invasive, accessible, and performed during routine appointments.
Clinically Actionable Insights
Dr. Noon delivers clear, validated results that support earlier decisions, smarter referrals, and more effective care.
Low-friction rollout.
High-throughput potential.
Designed for effortless deployment with minimal setup and a compact footprint (fundus camera-based), suitable for exam rooms, wellness suites, or pop-up screening spaces.
Supports flexible deployment using existing in-house imaging or community optometry fundus capture, without requiring specialist cardiovascular hardware.
Workflow integration support
Guidance to embed Dr. Noon into existing pathways
Dedicated support team
Setup, troubleshooting, ongoing guidance
Training & education
Live demos, guides, ongoing sessions
Comprehensive resources
FAQs, manuals, best practices
See Dr. Noon in practice
Hear from eye care professionals using Dr. Noon in everyday care and how it fits into routine eye exams.
Dr. Rachael Cave
GP - Beard Medical
Trusted recognition from healthcare and innovation awards
2025 Digital Health Awards
Rising star winner
Top Innovator Awards
2025
CKD Challenge 2024
1st place winner
2023 CES Innovation
Awards
1st place winner in two
categories 2024
Bring earlier risk insight into routine care
Start transforming healthcare today.
Seamless onboarding with training and dedicated support.
Evidence-backed. Clinically validated
Dr. Noon technology is supported by over 50 peer-reviewed publications across leading medical journals, demonstrating performance in cardiovascular and retinal disease detection.